Skip to content

Mark P. Hatton

NPI 1033198098ActiveIndividual· Ophthalmology, Ophthalmic Plastic and Reconstructive Surgery· Boston, MA

Ophthalmology, Ophthalmic Plastic and Reconstructive Surgery in Boston, Massachusetts, licensed in MA, with an NPI issued in January 2006. Part D covered 11 prescriptions written in 2024, 100% of them generic. Regeneron Pharmaceuticals, Inc. reported $224.85 in payments in 2024, mostly travel and lodging.

Overview

NPI1033198098
StatusActive
Entity typeIndividual
Sole proprietorNo
NPI issuedJan 10, 2006
Last updated in NPPESDec 20, 2021
Certified by providerDec 20, 2021

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Part D prescriptions in 2024

Prescriptions (claims)11 · 11 30-day fills
Total drug cost$33.00
Generic share100% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2024$224.85 · 2 payments from 1 company

Top paying companies in 2024

CompanyAmountPayments
Regeneron Pharmaceuticals, Inc.$224.852

What the 2024 payments were for

  • Travel and Lodging$205.88 · 1 payment
  • Food and Beverage$18.97 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Ophthalmology, Ophthalmic Plastic and Reconstructive Surgery providers in Boston

All Ophthalmology, Ophthalmic Plastic and Reconstructive Surgery providers in Massachusetts